AMGEN Congress Hub FAQs - Answers To Common Questions

  • This Amgen Congress Hub is designed for healthcare professionals and US audiences only.
    It has been reviewed in accordance with our US headquarters policies.

  • Amgen

FAQs

Here are some of the Amgen Virtual Congress Hub frequently asked questions

  • The Amgen Virtual Congress Hub is an online destination for timely, relevant, scientific data.
  • As a values-based company, Amgen strives to provide relevant information rooted in science and innovation to transform new ideas and discoveries into treatments for patients with serious illnesses.
  • If you would like more information about Amgen and its business, please visit About Amgen.

  • The Virtual Congress Hub is for members of the medical community (healthcare practitioners, associated team members, payors, and academics) seeking flexible access to conference materials from Amgen—no sign-up required.
  • The Virtual Congress Hub brings desired content to in-person and remote attendees looking for more information.

  • This site focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation.
  • Our medicines typically address diseases for which there are limited treatment options or seek to fulfill an unmet need.

  • Please review the Amgen Congress Hub schedule for upcoming congresses that may be of interest to you.

  • Please visit Amgen Pipeline and Clinical Trials for more information on our robust pipeline, which leverages state-of-the-art science and molecular engineering in the pursuit of transformative medicines for large effects in serious diseases.

  • Please find additional product information on Amgen’s Our Products page. Please note, this content is intended only for residents of the United States.
  • For information regarding FDA-approved biosimilar products, please visit Amgen Biosimilars.